No Wait, it works!

Alzheimer; News from the web:

The drug company Biogen is asking the FDA to approve one of its Alzheimer’s treatments, a sign that clinical trials have shown success for the therapy. The drug, aducanumab, is still in the experimental stages, and Biogen had thrown in the towel months ago when studies didn’t seem to show progress. The company now says higher doses may be key. An Alzheimer’s drug gaining FDA approval would be blockbuster. There are currently no effective treatments for the memory-robbing disease, which affects more than 5 million people in the U.S. alone

Read all about it HERE

A possible treatment

Alzheimer; News from the web:

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a possible treatment for Alzheimer’s disease. Working together with a scientific team at the Rockefeller University in New York, the investigators have shown that treatment with the oral anticoagulant dabigatran delays the appearance of Alzheimer’s disease in mice.

Read all about it HERE

New wearable device brings hope

Alzheimer; News from the web:

An open-label clinical trial working with eight people with Alzheimer’s disease concluded that a new wearable device that emits electromagnetic impulses was able to significantly improve memory loss in seven of these participants within 2 months.

Read all about it HERE